Rocky Mountain Poison & Drug Safety (rmpds)

What Rocky Mountain Poison & Drug Safety (rmpds) does

Rocky Mountain Poison & Drug Safety (RMPDS) is a division of Denver Health and Hospital Authority (DHHA), a body corporate and political subdivision of the State of Colorado. Established in 1956 as the Rocky Mountain Poison Center, RMPDS has provided 24-hour poison emergency services for over 65 years and currently operates poison center services for four states—Colorado, Hawaii, Montana, and Nevada. The organization managed approximately 92,988 exposure cases in 2021, with 87% of exposures managed at home, generating $30M in healthcare cost savings. Its clinical staff includes 21 MDs/PhDs, 19 PharmDs, 36 master's-level professionals, board-certified medical toxicologists, clinical toxicologists, toxicology fellows, registered nurses, and pharmacists, supplemented by a TELETOX telemedicine service for remote toxicological consultations.

The organization's core technology is the RADARS® (Researched Abuse Diversion and Addiction-Related Surveillance) System, an innovative postmarketing and public health surveillance system launched in 2006 that monitors abuse, misuse, and diversion of prescription drugs and other substances across multiple data sources including Poison Center reports, opioid treatment data, drug diversion tracking, and survey programs. RADARS has produced 110+ manuscripts, 202+ abstracts, and 57+ presentations. Around this core, RMPDS offers a portfolio of service modules: Medical Information and Pharmacovigilance, Postmarketing Surveillance, Consumer Product and Chemical Exposure Management, Consulting, Scientific Communication, Clinical Research, Regulatory Services, and Patient Health and Medical Toxicology Services. Specialty offerings include the Battery Ingestion Hotline (1-800-498-8666), the Psychedelic Studies research program, an Annual Scientific Meeting, and a public-facing drug use data dashboard.

RMPDS operates a hybrid revenue model combining state government contracts for poison center services, RADARS System subscriptions from pharmaceutical manufacturers and government/non-government agencies, and donations processed through the Denver Health Foundation. The organization is not a publicly traded company and is not venture-backed; it is government-funded through its parent entity. RMPDS holds ISO 9001:2015 Platinum certification with zero findings covering its Medical Information Contact Center and Pharmacovigilance functions. The organization is actively expanding into emerging verticals including psychedelic therapy surveillance and cosmetics/consumer product safety through new partnerships such as the 2025-09 collaboration with Registrar Corp.

Name

Rocky Mountain Poison & Drug Safety (rmpds)

Legal name

Rocky Mountain Poison & Drug Safety (RMPDS), a division of Denver Health and Hospital Authority (DHHA)

Website

https://www.rmpds.org

Company type

Private

Operating status

Operating

Short description

Rocky Mountain Poison & Drug Safety (RMPDS) is a division of Denver Health and Hospital Authority providing 24/7 poison center services in four states and operating the RADARS System for prescription drug abuse surveillance, serving state governments, pharmaceutical manufacturers, and consumer products companies.

Ownership category

akta.pro rank

Product category

Poison Control & Drug Safety Services

SIC

Services-Health Services (8000)

akta.pro primary industry

Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)

akta.pro secondary industries

Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH), Safety & Medical Contact Centers (AE Intake/Call Centers) (HLAGALAI)

Keywords

• Poison control services
• Pharmacovigilance services
• Drug safety surveillance
• Postmarketing surveillance
• Medical toxicology consulting

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. RADARS System Subscriptions: The RADARS System is supported by subscriptions from pharmaceutical manufacturers, government and non-government agencies for surveillance, research and reporting services.
2. State/Government Poison Center Contracts: Poison center services for Colorado, Hawaii, Montana, and Nevada provided through state government contracts and funding arrangements.
3. Donations: Accepts donations via mail or online through Denver Health Foundation, designated for Rocky Mountain Poison & Drug Safety.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

RMPDS operates 24/7 poison emergency centers serving Colorado, Hawaii, Montana and Nevada, and provides subscription-based drug safety surveillance through its proprietary RADARS System, along with medical information, pharmacovigilance, postmarketing surveillance, consumer product exposure management, consulting, psychedelic studies, clinical research, regulatory and toxicology services for pharmaceutical manufacturers, government agencies and consumer products companies.

Product overview

Rocky Mountain Poison & Drug Safety operates as a multi-service healthcare organization providing specialized research, education, prevention, and treatment services. The core offering is the RADARS® System for postmarketing surveillance of prescription drug abuse, misuse, and diversion. Supporting this core system are multiple service modules including Medical Information and Pharmacovigilance, Postmarketing Surveillance, Consumer Product and Chemical Exposure Management, Consulting, Clinical Research, Scientific Communication, Regulatory Services, and Patient Health and Medical Toxicology Services. The organization also operates poison center services for Colorado, Hawaii, Montana, and Nevada (handling ~300 overdoses, 87k cases managed annually), a Battery Ingestion Hotline, Psychedelic Studies research program, and provides public data dashboards and publications. All services are ISO 9001:2015 certified through Denver Health.

Differentiator

Problem solved

Functional benefit

Products and services

• RADARS System Proprietary postmarketing and public health surveillance system that monitors prescription drug abuse, misuse and diversion across multiple data sources and methodologies; licensed/subscribed to by pharmaceutical manufacturers and government agencies for surveillance, research and reporting.
• Poison Center Services (Colorado, Hawaii, Montana, Nevada) 24-hour poison emergency hotline and toxicological consultation services for the states of Colorado, Hawaii, Montana and Nevada, delivered by registered nurses, pharmacists, physicians and specialists who manage exposure cases and provide clinical guidance.
• Battery Ingestion Hotline National hotline (1-800-498-8666) providing 24/7 guidance on button and disc battery ingestion cases, staffed by trained nurses, pharmacists and toxicologists.
• Medical Information and Pharmacovigilance US-based pharmacist-led contact center providing empathetic, non-scripted conversational medical information, adverse event intake, product complaint handling and pharmacovigilance support to help pharmaceutical clients navigate regulatory requirements for new and existing products.
• Postmarketing Surveillance Multi-source, multi-methodology postmarketing surveillance service for pharmaceutical clients that delivers complete, representative information to optimize the therapeutic potential and safety profile of products after launch.
• Consumer Product and Chemical Exposure Management Toxicology-led service supporting consumer products and chemicals companies in managing exposure risk, providing expert guidance to safely and responsibly bring products to market and mitigate risks to consumers.
• Consulting Expert consulting engagements covering risk assessment, signal detection, data analysis and other drug and consumer product lifecycle safety elements for pharmaceutical and consumer products clients.
• Patient Health and Medical Toxicology Services Medical toxicology service line that includes TELETOX telemedicine for enhanced toxicological assessment, providing hospitals, healthcare providers and poison centers access to specialist toxicology consultations.
• Public Data Dashboard Interactive online dashboard presenting RADARS System data on drug use, misuse, abuse and diversion in the United States since 2006, with topic tabs and drug selection tools for public exploration.
• Regulatory Services Regulatory compliance and submission support services for pharmaceutical and consumer products clients navigating FDA and other regulatory requirements.
• Clinical Research Clinical research services supporting pharmaceutical and consumer products companies, leveraging the RADARS System and clinical toxicology expertise for sponsored studies.
• Scientific Communication Scientific writing, publication planning and communication services for disseminating research findings and medical information for pharmaceutical and consumer products clients.
• Psychedelic Studies Research program developing fit-for-purpose surveillance tools to monitor the safety and effectiveness of psychedelic therapies, including the 2024 Fit-For-Purpose Psychedelic Monitoring Framework.
• Poison Prevention Educator Training Program Free online training course certifying participants as Poison Prevention Educators, covering poisoning problems, common poisons, prevention strategies and emergency response, available to residents of Colorado, Nevada, Montana and Hawaii.

Quantifiable outcome

• $30M healthcare costs saved (2021)
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Registrar CorpminorStrategic or Co-development Partner · 1 September 2025Registrar Corp and Denver Health announced Adverse Event Protection Program to safeguard consumers and cosmetics brands, combining RMPDS toxicology expertise with Registrar Corp's regulatory compliance services.
• Denver Health and Hospital AuthoritycoreStrategic or Co-development PartnerRMPDS is a division of Denver Health and Hospital Authority, an acute care academic safety net hospital and community health system for the Denver area. Denver Health retains exclusive ownership of all RADARS System data, databases and systems.
• Denver Health FoundationminorOthersDonations to RMPDS are processed through the Denver Health Foundation. Donors select 'Other' in FUND dropdown and specify 'Rocky Mountain Poison & Drug Safety' or 'RMPDS' in comments.

Scale indicators17 records

Recent moves6 records

Expansion highlights12 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO with dedicated pharmacovigilance and medical affairs services. Most directly comparable to RMPDS among CROs because of its PV-centric service orientation and pharma subscription-style engagements.
• PharmaLex: Specialized pharmacovigilance, regulatory, and medical affairs services provider. Comparable to RMPDS as a PV-focused services firm supporting pharma manufacturers with safety and regulatory workflows, including AE intake and reporting.
• ArisGlobal: Vendor of LifeSphere Safety Suite, an integrated pharmacovigilance and safety database platform. Comparable to RMPDS as a technology-and-services provider in the PV value chain, though ArisGlobal is primarily a software vendor rather than a service operator.

Broad incumbents

• Syneos Health: Clinical and commercial solutions organization with pharmacovigilance and safety services. Overlaps with RMPDS on postmarketing surveillance and adverse-event case processing for pharma clients, while also running full clinical development programs.
• IQVIA: Global CRO and healthcare data analytics firm with a large dedicated pharmacovigilance and postmarketing surveillance practice. Comparable to RMPDS as a scaled provider of PV and drug-safety services to pharmaceutical manufacturers, though IQVIA's portfolio spans clinical trials, real-world evidence, and broader commercial services.
• Labcorp Drug Development (formerly Covance): Large CRO and central lab with pharmacovigilance, clinical safety, and postmarketing surveillance offerings. Comparable to RMPDS as a full-service drug-safety provider to pharma, with broader clinical and diagnostic capabilities.
• Parexel International: Global CRO offering comprehensive pharmacovigilance, regulatory, and postmarketing services to pharma and biotech. Comparable to RMPDS in serving pharma PV needs but operating at much larger scale and broader service breadth.
• Oracle Health Sciences (Argus Safety): Provider of Argus Safety, the most widely deployed safety database in pharma. Comparable to RMPDS as a foundational infrastructure layer for adverse-event case management, though Oracle's role is software/hosting rather than outsourced case processing.

Emerging players

• Veeva Systems (Vault Safety): Cloud life-sciences software vendor whose Vault Safety product competes in the pharmacovigilance platform market. Comparable to RMPDS as an emerging challenger in PV technology, though Veeva is software-only and does not perform PV services operationally.

Others

• Uppsala Monitoring Centre: WHO Collaborating Centre for International Drug Monitoring that maintains VigiBase, the global pharmacovigilance database. Comparable to RMPDS as a global PV data steward, though UMC is an intergovernmental/non-profit rather than a commercial PV operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/RMPDC1956
• LinkedInlinkedin.com/company/20125402

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rocky Mountain Poison & Drug Safety (rmpds)